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Objective: Hepatocyte growth factor (HGF) and its receptor MET are expressed in the salivary glands dur-
ing developmental stages and tumor formation; however, the function of HGF in injured salivary gland
tissues remains unclear. The present study investigated the role of HGF in protecting the salivary glands
against radiation-induced injury using an organotypic culture method.
Materials and methods: Acinar-like organoids were formed by means of a three-dimensional (3D) human
parotid tissue-derived spheroids (hPTS) culture method. Radioprotective effects of HGF on irradiated
hPTS and signaling pathways on radioprotection were investigated.
Results: We detected MET expression in hPTS grown in a 3D culture. Treatment of irradiated hPTS with
recombinant human HGF (rhHGF) restored salivary marker expression and secretory function of hPTS.
Changes in the phosphorylation levels of apoptosis-related proteins through HGF-MET axis inhibited
radiation-induced apoptosis. Treatment with PHA665752, a MET inhibitor, blocked MET-PI3K-AKT path-
way, increased apoptosis, and suppressed the radioprotective effect of rhHGF against IR-induced damage
of hPTS.
Conclusions: These results suggest that HGF is a key effector of radioprotection and that HGF-MET-PI3K-
AKT axis is involved in protecting the salivary glands from radiation-induced apoptosis.
 2019 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 138 (2019) 9–16 This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Almost 500,000 patients are annually diagnosed with head and
neck cancer worldwide, and many of them are treated with radio-
therapy [1]. Despite recent advances in technology for decreasing
radiation dose and volume reaching surrounding normal tissues,
approximately 40% long-term cancer survivors develop irradiation
(IR)-induced salivary gland hypofunction [2,3]. Salivary hypofunc-
tion leads to intractable xerostomia (dry mouth)-related complica-
tions such as oral soreness, mastication and swallowing difficulties,
speech impairment, and increased oral infection and dental caries
risk. Xerostomia significantly decreases the quality of life of
patients, however, palliative management methods for xerostomia,
such as the use of sialogogues or saliva substitutes, are only avail-
able in clinical setting. This highlights the need for developing
radioprotection and/or regeneration strategies.
Cytoprotective agents, including biologic molecules, growth
factors, and cytokines, have been suggested to protect or amelio-rate radiation damage [4,5]. We used an organotypic three-
dimensional (3D) human parotid tissue-derived spheroids (hPTS)
culture method to show that IR-induced salivary hypofunction
can be mitigated using growth factors that prevent human parotid
epithelial cell (hPEC) apoptosis [6–8]. We recently found that
adipose-derived mesenchymal stem cells (AdMSCs) under hypoxia
inhibit the apoptosis of irradiated hPTS and hypoxia-stimulated
AdMSCs secret several growth factors, including hepatocyte
growth factor (HGF) [8,9]. Hepatocyte growth factor (HGF) is
secreted during liver injury and promotes regeneration of damaged
tissues [10]. HGF that is activated during tissue damage exerts
antiapoptotic, proangiogenic, and mitogenic effects in various
organs [11,12]. Xiong et al. suggested that HGF mRNA is highly
expressed in the salivary glands of irradiated rats during recovery,
implying that HGF plays a role in the cytoprotection of the salivary
glands [13]. However, the exact role of HGF in the cytoprotection of
the salivary glands is unclear.
The present study is the first to show that HGF exerts an anti-
apoptotic effect, prevents IR-induced apoptosis in salivary glands,
and preserves the function of IR-damaged hPTS. Moreover, this
study showed that HGF protects against IR-induced damage by
activating MET-PI3K-AKT pathway. These results suggest that
HGF is a key effector of radioprotection of the salivary glands.
10 Radioprotection of HGF against injury of salivary glandsMaterials and methods
Three-dimensional human parotid tissue-derived spheroid culture and
in vitro irradiation
A specimen was obtained from a patient with benign tumor
through parotidectomy after acquiring the patient’s informed con-
sent and approval from the institutional review board (IRB No.
2015-10-001). The obtained specimen was washed three times
with 1 cold PBS (Gibco, Grand Island, NY, USA) containing 1%
antibiotic, chopped, and incubated in HBSS (Gibco) containing
0.25% collagenase type II (2.5 mg/mL; Sigma-Aldrich, St. Louis,
MO, USA) and DNase I (1 mg/mL; Sigma-Aldrich) with shaking at
37 C for 30 min. Cell suspension obtained was filtered through a
70-lm cell strainer and centrifuged at 500g for 5 min. Cell pellet
obtained was cultured in a keratinocyte-serum-free medium
(Gibco) supplemented with 5 ng/mL epidermal growth factor, 50
lg/mL bovine pituitary extract, 0.09 mM calcium chloride, and
1% antibiotic–antimycotic (Gibco). The cultured cells were seeded
(density, 1  104 cells/cm2) in a growth factor-reduced Matrigel
(GFR-Matrigel)-precoated plate (Corning, Corning, NY, USA). The
seeded hPECs were allowed to form three-dimensional (3D) spher-
oids on the GFR-Matrigel for 72 hours. Next, the cells were irradi-
ated with 10-Gy radiation by using a 4-MV X-ray linear accelerator
(Mevatron MD; Siemens Medical Laboratories Inc., Germany). The
radiation dose was chosen based on IC50 dose used in our previous
study [14].Antibodies and reagents
Antibodies against MET (dilution, 1:1000), ZO-1 (dilution,
1:1000), phosphorylated PI3K (p-PI3K; Y508) (dilution, 1:1000),
phosphorylated BCL-2 antagonist of cell death (BAD) (p-BAD;
S136) (dilution, 1:1000), and b-actin (dilution, 1:1000) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Antibodies against a-amylase (a-Amy) (dilution, 1:1000), E-
cadherin (dilution, 1:1000), phosphorylated p53 (p-p53; S15)
(dilution, 1:1000), BAX (dilution, 1:1000), cleaved caspase-9 (dilu-
tion, 1:1000), cleaved caspase-3 (dilution, 1:1000), and BCL-2
(dilution, 1:1000) were obtained from Cell Signaling Technology
(Danvers, MA, USA). Antibodies against phosphorylated c-H2AX
(S139) (dilution, 1:1000), phosphorylated AKT (p-AKT; S473) (dilu-
tion, 1:1000), phosphorylated MDM2 (p-MDM2; S166) (dilution,
1:1000), PTEN (dilution, 1:1000), and phosphorylated MET (p-
MET; Y1230, Y1234, and Y1235) (dilution, 1:1000) were obtained
from Abcam (England). Antibody against aquaporin 5 (AQP5) (dilu-
tion, 1:1000) was obtained from Calbiochem (San Diego, CA, USA).
Recombinant human HGF (rhHGF) was purchased from R&D Sys-
tems, Minneapolis, MN, USA.Table 1
Primers used for performing RT-PCR.
Gene and symbol Primer sequences (50-30)
a-Amylase (AMY1A) F AATTGATCTGGGTGGTGAGC
R CTTATTTGGCGCCATCGATGWestern blotting analysis
Cell lysates were prepared using a whole cell lysis buffer con-
taining 2% SDS (pH 6.8). Total proteins and histones present in
the cell lysates were separated on an SDS–PAGE gel and were elec-
trotransferred to a PVDF membrane. Proteins of interest were
detected by incubating the membrane with the indicated primary
antibodies. The experiment was repeated at least three times
independently.Aquaporin 5 (AQP5) F ACTGGGTTTTCTGGGTAGGG
R GTGGTCAGCTCCATGGTCTT
E-cadherin (CDH1) F CGCATTGCCACATACACTCT
R TTGGCTGAGGATGGTGTAAG
ZO-1 (TJP1) F TTTGGCCGAGGGATAGAAGT
R TATTGCCATCTCTTGCTGCC
Beta-actin (ACTB) F AGCTGTGCTATGTTGCCCTG
R AGGAAGCAAGGCTGGAAGAGHGF concentration measurement
The concentration of hPEC-secreted HGF was measured by per-
forming a sandwich enzyme-linked immunosorbent assay (ELISA)
with a commercial kit (Quantikine; R&D Systems), according to
the manufacturer’s protocol. Samples from each group collectedat different time points were assayed in triplicate, and absorbance
was read at 450 nm. HGF concentration in each sample was deter-
mined by plotting optical density of the sample against a standard
curve.Cell viability assay
hPEC viability was determined by performing 3-(4,5-dimethyl
thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS) assay. For this, 20 lL MTS (Promega Corpora-
tion, Madison, WI, USA) was added to each sample. After incuba-
tion for 1 hour, 100 lL mixture was transferred to a 96-well
microplate and absorbance was measured at 490 nm. The experi-
ment was repeated at least three times.Terminal deoxynucleotidyl transferase dUTP nick end labeling assay
For performing terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) assay, hPTS were washed and fixed in
4% phosphate-buffered paraformaldehyde for 25 min at room tem-
perature (RT). After washing three times with PBS, the cells were
stained with in Situ Cell Death Detection Kit (Roche Diagnostics,
Laval, Quebec, Canada), according to the manufacturer’s protocol.Immunofluorescence microscopy
For this, the hPTS were washed, fixed in 4% phosphate-buffered
paraformaldehyde for 25 min at RT, and permeabilized with 0.4%
Triton X-100 in 1 PBS for 10 min at RT. After washing three times
with PBS, the spheroids were incubated for 1 hour in PBS contain-
ing 1% BSA, followed by overnight incubation at 4 C with the pri-
mary antibodies against c-H2AX, a-Amy, AQP5, E-cadherin, and
ZO-1 that were diluted in PBS containing 1% BSA. After washing
three times with PBS, the samples were incubated with primary
antibody-specific secondary antibodies diluted in PBS for 1 hour
at RT in a dark room and were washed three times with PBS. Nuclei
were counterstained with DAPI. The samples were visualized
under Axiovert 200 fluorescence microscope (Carl Zeiss, Goettin-
gen, Germany) with 10  10 and 20  10NA objectives equipped
with AxioCam HRC digital camera (Carl Zeiss).Real-time polymerase chain reaction
Transcript levels were determined by performing real-time
polymerase chain reaction (RT-PCR) with an ABI system and
PowerUpTM SYBRTM Green Master Mix (Applied Biosystems, Foster
City, CA, USA). PCR was performed in a 20 lL reaction mixture con-
taining 50 ng cDNA, SYBR Green PCR master mix, and 10 pM sense
and antisense primers specific for the genes encoding a-Amylase
(AMY1A), Aquaporin 5 (AQP5), E-cadherin (CDH1), and ZO-1 (TJP1)
(Table 1). Relative gene expression was quantified by normalizing
with the housekeeping gene b-actin expression.
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Amylase activity in the secreted hPTS was determined using a
salivary a-amylase assay kit (Salimetrics LLC, State College, PA,
USA) with maltotriose-linked 2-chloro-p-nitrophenol as a chro-
mogenic substrate, according to the manufacturer’s instructions.
Amylase activity in the sample was directly proportional to the
increase in absorbance at 405 nm determined using a standard lab-
oratory plate reader.Statistical analysis
All experiments were performed at least three times. Results
are presented as mean with standard deviation (SD). Statistical
analyses were performed using GraphPad Prism 6.01 (GraphPad
Software Inc., San Diego, CA, USA). *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001 were considered to be statistically
significant, and p > 0.05 was considered statistically not significant.Results
Human parotid epithelial cells express MET and rhHGF does not affect
cell viability
First, we isolated and cultured human parotid epithelial cells
(hPECs), as described previously [6]. MET expression was detected
in both 2D hPEC and 3D hPTS cultures in Matrigel. However, RT-
PCR and western blotting analysis showed that MET expression
was higher in 3D hPTS culture than in 2D single-layered hPEC cul-
ture (Fig. 1A, B). Next, we measured the concentration of HGF
secreted by hPECs in 2D culture by performing ELISA. HGF concen-
tration was almost the same in cultures with and without hPECs,
and there was no cumulative amount of hPECs up to 72-hour cul-Fig. 1. Characterization of hPECs. (A) MET mRNA level in the 2D hPEC and 3D hPTS cultu
using the mRNA expression level of the b-actin gene (n = 6 for each group); p values were
MET precursor and subunits in the 2D and 3D cultures. (C) Determination of the concent
was determined by performing the trypan blue exclusion andMTS assays. Results are exp
way analysis of variance (ANOVA) with Bonferroni’s post-hoc test.ture (Fig. 1C). Because HGF exerts a mitogenic effect, we examined
whether HGF affected cell viability or growth in 2D culture under
normal condition by performing trypan blue exclusion assay and
MTS assay. Treatment with up to 200 ng/mL rhHGF did not affect
cell viability or growth (Fig. 1D, E). Together, these results indicate
that hPECs express MET, an HGF receptor, more in 3D spheroid cul-
ture but do not express HGF and that treatment with exogenous
HGF under normal condition does not affect hPEC growth.Exogenous rhHGF treatment prevents IR-induced DNA double-
stranded breaks and apoptosis in a dose-dependent manner
We next investigated whether MET expression is activated after
irradiation damage to salivary gland. hPTS was irradiated with 10-
Gy, and the change in MET expression was confirmed by western
blot. Expression of MET increased at 6 hours after irradiation,
and eventually decreased over time (Fig. 2A). To explore the effects
of exogenous rhHGF in inducing radioprotection against IR-
induced damage in the salivary glands, hPTS were then incubated
with 50, 100, and 200 ng/mL rhHGF immediately after IR. Treat-
ment with rhHGF significantly improved the cell viability and mor-
phology of hPTS in a dose-dependent manner at 48 hours after
treatment with 10-Gy radiation compared with those of irradiated
cells not treated with rhHGF (Fig. 2B, C). Assessment of the effect of
rhHGF on the recovery of cell viability and morphology suggested
that 100 ng/mL was effective concentration of rhHGF. Therefore,
this rhHGF concentration was used for performing subsequent
experiments.
Next, we investigated whether IR induced apoptosis by per-
forming TUNEL assay, which detects apoptotic DNA fragments or
extreme DNA damage [17]. The number of TUNEL-positive cells
significantly decreased after rhHGF treatment (Fig. 3A). Moreover,res. Relative fold change in the mRNA expression level of each gene was normalized
determined using an unpaired t-test withWelch’s correction. (B) Expression levels of
ration of HGF secreted by hPECs in culture medium. (D and E) Relative cell viability
ressed as mean ± SD (n = 3); p values shown in (D and E) were determined using one-
Fig. 2. HGF treatment inhibits the apoptosis of irradiated hPTS. (A) Expression levels of MET in the hPTS irradiated with 10-Gy radiation and incubated for 48 hours were
determined by performing western blotting analysis, with b-actin as the loading control. (B and C) Treatment of hPTS with the indicated concentration of HGF immediately
after IR. (B) Relative cell viability was measured by performing the MTS assay at 48 hours after the IR. Results are expressed as mean ± SD (n = 3); p values were determined
using ANOVA with the Bonferroni’s post-hoc test. (C) Difference in the morphology of the irradiated hPTS; scale bars represent 20 lm.
12 Radioprotection of HGF against injury of salivary glandsthe number of TUNEL-positive cells was higher in irradiated hPTS
than non-irradiated hPTS. Next, we assessed DNA double-
stranded breaks (DNA-DSBs) and apoptotic DNA fragmentation
by performing c-H2AX immunofluorescence staining. We observed
that rhHGF treatment decreased the proportion of DNA-DSBs
(Fig. 3B). To elucidate mechanisms underlying IR-induced apopto-
sis, we explored changes in the expression of apoptosis-related
proteins. Expression levels of p-p53, its proapoptotic target BAX,
cleaved caspase-9, and cleaved caspase-3 increased and that of
the antiapoptotic protein BCL-2 decreased after IR (Fig. 3C, lane
2). However, treatment of rhHGF decreased IR-induced apoptosis
and proapoptotic protein expression in hPTS (Fig. 3C, lane 3). Den-
sitometric analysis of the results of western blotting analysis
clearly showed the changes in the apoptosis-related protein levels
(Fig. 3D). Together, these data suggest that rhHGF exerts antiapop-
totic effects on IR-damaged hPTS by inhibiting an apoptosis
pathway.Exogenous rhHGF treatment protects and rescues the function of hPTS
from IR-induced damage
We previously found that irradiated hPTS cultured in GFR-
Matrigel showed the loss of structural protein expression and
secretory function [6]. Therefore, we investigated whether exoge-
nous rhHGF treatment maintained the structure and function of
irradiated hPTS. Fluorescence microscopy indicated that the
expression of acinar markers a-Amy and AQP5markedly decreased
(Fig. 4A, row 2) and that the expression of epithelial cell markers E-
cadherin and ZO-1 was negligible in irradiated hPTS. However,
rhHGF treatment immediately after the IR increased the expression
of the acinar and epithelial cell markers in hPTS (Fig. 4A, row 3).
Western blotting analysis also showed that the expression of theacinar and epithelial cell markers decreased in the lysates of irradi-
ated hPTS (Fig. 4B, lane 2) compared with that in the lysates of
non-irradiated hPTS (Fig. 4B, lane 1) and increased in the lysates
of irradiated hPTS treated with rhHGF (Fig. 4B lane 3). Consistently,
RT-PCR showed that rhHGF treatment rescued the expression of
the salivary acinar and epithelial cell marker genes (Fig. 4C). hPTS
secrete amylase [18]. Next, we measured amylase activity to con-
firm that rhHGF treatment restored the secretory function of irra-
diated hPTS. Treatment of irradiated hPTS with rhHGF significantly
increased the amylase activity (Fig. 4D). Together, these results
indicate that rhHGF treatment recovers structural protein expres-
sion in and secretory function of irradiated hPTS.Recombinant human HGF treatment induces radioprotection by
exerting an antiapoptotic effect by activating the MET-PI3K-AKT
pathway
Next, we explored whether the binding of HGF to its receptor
HGFR/MET activated PI3K-AKT signaling pathway as a radioprotec-
tive mechanism. PI3K-AKT pathway promotes cell survival by inac-
tivating proapoptotic effectors such as BAD and by suppressing
p53-mediated apoptotic signaling through the activation of
MDM2, a p53-interacting protein that downregulates p53 tran-
scriptional activity [19,20]. In the present study, IR decreased the
phosphorylation of MET, PI3K, AKT, BAD, and MDM2 and increased
the expression of PTEN in hPTS (Fig. 5A, lane 2). However, rhHGF
treatment increased the phosphorylation of MET, PI3K, AKT, BAD,
and MDM2 and decreased the expression of PTEN (Fig. 5A, lane
3). Blockade of the binding of HGF to MET by using an MET inhibi-
tor PHA665752 decreased the phosphorylation of MET, PI3K, AKT,
and MDM2 (Fig. 5A, lane 4). Results of the cell viability assay
showed that PHA665752 treatment decreased the viability of the
Fig. 3. HGF treatment inhibits the intrinsic apoptosis pathway in irradiated hPTS. (A and B) Representative images of the TUNEL assay and c-H2AX immunofluorescence
microscopy of hPTS treated with 10-Gy IR and incubated for up to 48 hours. Nuclei were counterstained with DAPI. Representative results are shown in the upper panels, and
average number of TUNEL-positive cells and c-H2AX foci in the irradiated hPTS compared with those in non-irradiated hPTS are shown in the lower panels. Results are
expressed as mean ± SD (n = 3); p values shown in (A and B) were determined using ANOVA with the Bonferroni’s post-hoc test. (C) Expression levels of p-p53, BAX, cleaved
caspase-9, cleaved caspase-3, and BCL-2 in the hPTS irradiated with 10-Gy radiation and incubated for 48 hours were determined by performing western blotting analysis,
with b-actin as the loading control. (D) Densitometric analysis of IR-induced alterations in apoptosis-related protein levels. Data were normalized using b-actin protein level.
Normalization intensity was analyzed and presented as mean ± SD (n = 3); p values were determined using ANOVA with the Bonferroni’s post-hoc test.
Y.J. Yoon et al. / Radiotherapy and Oncology 138 (2019) 9–16 13irradiated hPTS in the presence of rhHGF (Fig. 5B), which was con-
sistent with the results presented in Fig. 5A. However, rhHGF treat-
ment significantly improved the morphology and structural
protein expression in hPTS compared with those in rhHGF-
untreated irradiated hPTS and PHA665752-treated hPTS (Fig. 5C,
D). These results suggest that rhHGF induces radioprotection by
exerting an antiapoptotic effect by activating MET-PI3K-AKT
pathway.Discussion
Radiation-induced salivary gland dysfunction is attributed to
the destruction of terminally differentiated salivary gland cells
and/or loss of regenerative capacity of tissue-resident stem cells
or progenitor cells [21]. Preservation or restoration of salivary
gland function can be achieved by protecting salivary gland cells
from IR. We recently established an organotypic hPTS mimicking
Fig. 4. Effects of HGF on the structure and function of irradiated hPTS in 3D culture. (A) Immunofluorescence images showing the expression of acinar markers a-Amy (red)
and AQP5 (green), epithelial protein E-cadherin (red), and tight junction (TJ)-associated protein ZO-1 (green). Nuclei were stained with DAPI (blue). Scale bars represent
10 lm. (B) Protein expression of the salivary acinar markers (a-Amy and AQP5), adherent protein (E-cadherin), and TJ-associated protein (ZO-1) was determined by
performing western blotting analysis, with b-actin as the loading control. (C) The mRNA expression of the genes encoding these proteins was determined by performing RT-
PCR. Results are expressed as mean ± SD (n = 3). (D) Amylase secretion from the hPTS was determined using an assay kit. Results are expressed as mean ± SD (n = 3); p values
shown in (C and D) were determined using ANOVA with the Bonferroni’s post-hoc test. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
14 Radioprotection of HGF against injury of salivary glandsirradiation-induced salivary hypofunction, by which we could
evaluate the efficacy of a key factors released from stem cells by
paracrine effect without direct cell-to-cell contact or animal exper-
iments [6,14]. We employed organotypic hPTS culture in this study
and found that radiotoxic cell death of irradiated hPTS can be alle-
viated by administration of rhHGF. We observed that exogenous
rhHGF treatment inhibited the apoptosis in irradiated hPTS. The
rhHGF-treated cells showed deceased DNA fragmentation or
DNA-DSBs after IR, as determined by performing the TUNEL assay
or c-H2AX immunofluorescence staining. The rhHGF decreased
proapoptotic protein levels and increased antiapoptotic protein
levels. Furthermore, rhHGF treatment restored epithelial cell mar-
ker expression and a-amylase activity in hPTS in 3D culture. Theseresults suggest that HGF functions as a key effector of radioprotec-
tion against IR-induced salivary gland dysfunction by interacting
with MET.
HGF/MET signaling involves various essential biologic activities
in cells during development, regeneration, as well as progression to
solid tumors [11]. Although the physiologic function of HGF by
binding to MET in salivary glands has been reported during
branching morphogenesis [22,23], the exact role of HGF remains
undetermined in adult salivary glands. In developing salivary
glands, HGF and MET expressions have been noted in ductal cells
and stroma during developmental process [24]. However, MET
expression has not been observed neither in the membrane of
adult salivary ductal cells nor in acinar cells, whereas MET was
Fig. 5. Mechanism underlying the antiapoptotic effect of HGF through the MET-PI3K-AKT axis. (A–D) Supplementation of the hPEC culture medium with the indicated
concentration of HGF immediately after IR. (A) Expression levels of p-MET, p-PI3K, p-AKT, p-BAD, p-MDM2, and PTEN were determined by performing western blotting
analysis, with b-actin as the loading control. (B) Relative cell viability was measured by performing the MTS assay. Results are expressed as mean ± SD (n = 3); p values were
determined using ANOVA with the Bonferroni’s post-hoc test. (C) Difference in the morphology of the irradiated hPTS; scale bars represent 50 lm. (D) Protein levels of the
salivary acinar markers (a-Amy and AQP5), adherent protein (E-cadherin), and TJ-associated protein (ZO-1) were determined by performing western blotting analysis, with b-
actin as the loading control.
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dular organs, including the pancreas and liver [15,16]. Some stud-
ies have reported that increased HGF and MET expression levels
after radiation injury, which indicates regeneration potential of
HGF in salivary glands [25–27]. These highlight the importance
of assessing reparative or regenerative roles of HGF/MET pathway
in salivary glands. In this study, we showed MET expression in 3D
hPTS and 2D hPEC cultures. Treatment with rhHGF exerted the
antiapoptotic effect through MET-PI3K-AKT pathway, and these
effects of rhHGF were abrogated after treatment with MET inhibi-
tor PHA665752. These results imply that HGF/MET interaction
involves radioprotection against IR-induced salivary gland dys-
function [28,29]. Meanwhile, HGF/MET expressions were also
observed in ductal cells of benign or malignant salivary neoplasms
[24,30].
A recent study also showed that the inhibition of HGF/MET
pathway increases susceptibility to radiation therapy [31], which
is consistent with the results obtained using MET inhibitor in the
present study. Given that MET expression was also observed in
benign or malignant salivary neoplasms, more attention is needed
to harness HGF/MET pathway as a protective mechanism in sali-
vary gland cancer patients.
In this study, we adapted 10-Gy radiation dose as the radiation
dose at the level of IC50 referred from our previous study, and used
experimental conditions that have been described elsewhere
[14,32]. However, radiotherapy involves the use of a cumulative
dose of 50–70 Gy (e.g. 2 Gy/day). Therefore, animal experimentsare required to determine the appropriate dosage and administra-
tion frequency of rhHGF for application in human patients. It
should be also noted that this hPTS culture model may not repre-
sent various responses to radiation damage, since radiation
responses are complex in vivo according to interaction between
cells and their microenvironment as well as even between individ-
uals in vivo. Nevertheless, this IR experiment using 3D spheroid
culture enables elucidation of IR-induced cellular death mecha-
nism, providing information vital to the development of preventive
and therapeutic candidates against IR damage because IR to hPTS
assembled as acinar-like 3D structures were shown to be capable
of representing IR-induced SG hypofunction in vivo [14].
HGF exerts other cytoprotective effects such as inhibition of
autophagic cell death [33] and regulation of inflammation
[34,35]. Moreover, the body removes damaged cells and initiates
regeneration by inducing cell death and inflammation [36]. There-
fore, additional studies are needed to assess whether exogenous
HGF treatment affects these processes, which may affect the
expected outcomes of this treatment. Lastly, salivary paracrine fac-
tors such as epidermal growth factor (EGF), fibroblast growth fac-
tor (FGF), and insulin-like growth factor 1 (IGF-1) can also protect
irradiation-damaged salivary cells in a synergistic way [31,37,38].
Therefore, the complexity of action mechanisms of growth factors
involving tissue repair and/or regeneration in salivary glands
remains to be determined.
In conclusion, we examined the expression of MET and the role
of exogenous rhHGF in preserving the structure and secretory
16 Radioprotection of HGF against injury of salivary glandsfunction of irradiated hPTS in a 3D culture. Treatment with rhHGF
suppressed the IR-induced apoptosis in irradiated hPTS and pre-
served the structural marker expression and secretory function of
hPTS. Treatment with MET inhibitor blocked MET-PI3K-AKT path-
way, increased apoptosis, and suppressed the radioprotective
effect of rhHGF against IR-induced structural alteration and dys-
function, suggesting that HGF acts as a key effector of radioprotec-
tion by modulating MET-PI3K-AKT pathway. Although additional
studies are needed, the present study is the first to suggest the
potential of HGF for protecting the salivary glands from IR-
induced damage, and its results indicated that hPTS culture as a
reliable new ex vivo model for screening radioprotective agents.
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